Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Piehl

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Human Genetics|October 6, 1998
Characterization of the human synaptogyrin gene familyD Kedra, H Q Pan, E Seroussi, et al.
Acta Psychiatrica Scandinavica|August 23, 2018
Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosisF Orhan, L Schwieler, H Fatouros-Bergman, et al.
Genes and Immunity|January 17, 2014
Variability in the CIITA gene interacts with HLA in multiple sclerosisA Gyllenberg, F Piehl, L Alfredsson, et al.
Biochemical and Biophysical Research Communications|August 14, 2001
Menin interacts directly with the homeobox-containing protein PemI H Lemmens, L Forsberg, A A Pannett, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 7, 2000
Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cellsH Hammarberg, O Lidman, C Lundberg, et al.
Annals of Clinical and Translational Neurology|April 13, 2026
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing-Remitting MSF Shawket, J Lycke, J Salzer, et al.
Multiple Sclerosis and Related Disorders|October 15, 2022
Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosisH Tedeholm, F Piehl, J Lycke, et al.
Journal of Internal Medicine|April 19, 2021
Neurofilament light chain as a marker for cortical atrophy in multiple sclerosis without radiological signs of disease activityB V Ineichen, T Moridi, E Ewing, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 6, 2012
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugsH Tedeholm, J Lycke, B Skoog, et al.
Acta Neurologica Scandinavica|August 26, 2016
Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological SocietyM Vågberg, M Axelsson, R Birgander, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Human Genetics|October 6, 1998
Characterization of the human synaptogyrin gene familyD Kedra, H Q Pan, E Seroussi, et al.
Acta Psychiatrica Scandinavica|August 23, 2018
Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosisF Orhan, L Schwieler, H Fatouros-Bergman, et al.
Genes and Immunity|January 17, 2014
Variability in the CIITA gene interacts with HLA in multiple sclerosisA Gyllenberg, F Piehl, L Alfredsson, et al.
Biochemical and Biophysical Research Communications|August 14, 2001
Menin interacts directly with the homeobox-containing protein PemI H Lemmens, L Forsberg, A A Pannett, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 7, 2000
Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cellsH Hammarberg, O Lidman, C Lundberg, et al.
Annals of Clinical and Translational Neurology|April 13, 2026
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing-Remitting MSF Shawket, J Lycke, J Salzer, et al.
Multiple Sclerosis and Related Disorders|October 15, 2022
Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosisH Tedeholm, F Piehl, J Lycke, et al.
Journal of Internal Medicine|April 19, 2021
Neurofilament light chain as a marker for cortical atrophy in multiple sclerosis without radiological signs of disease activityB V Ineichen, T Moridi, E Ewing, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 6, 2012
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugsH Tedeholm, J Lycke, B Skoog, et al.
Acta Neurologica Scandinavica|August 26, 2016
Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological SocietyM Vågberg, M Axelsson, R Birgander, et al.
Pageof 9